Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reichardt

Showing results (61-70 of 193) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|December 22, 2005
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literatureDaniel Pink, Tanja Lindner, Alicia Mrozek, et al.
Seminars in Oncology|August 12, 2009
Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issuesPeter Reichardt, Pancras C W Hogendoorn, Elena Tamborini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2023
Evaluation of electronic patient-reported outcome assessment in inpatient cancer care: a feasibility studyHanna Salm, Leopold Hentschel, Martin Eichler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2014
Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalanDimosthenis Andreou, Henrike Boldt, Daniel Pink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Acute hypokalemic tetraparesis induced by intravenous methotrexatePeter C Thuss-Patience, Uwe Peters, Karin Jurkat-Rott, et al.
Immunologic Research|June 8, 2004
Defining the parameters necessary for T-cell recognition of ligands that vary in potencyNeely E Kilgore, Mandy L Ford, Carrie D Margot, et al.
Anti-Cancer Drugs|September 10, 2003
Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II studyPeter C Thuss-Patience, Gunter von Minckwitz, Albrecht Kretzschmar, et al.
Investigational New Drugs|October 31, 2003
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcomaPeter Reichardt, Karin Oechsle, Daniel Pink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two casesDaniel Pink, Dagmar Schoeler, Tanja Lindner, et al.
Journal of Immunological Methods|November 27, 2012
Analysis of TCR activation kinetics in primary human T cells upon focal or soluble stimulationBoerge Arndt, Mateusz Poltorak, Bhavani S Kowtharapu, et al.
Pageof 20

Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|December 22, 2005
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literatureDaniel Pink, Tanja Lindner, Alicia Mrozek, et al.
Seminars in Oncology|August 12, 2009
Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issuesPeter Reichardt, Pancras C W Hogendoorn, Elena Tamborini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2023
Evaluation of electronic patient-reported outcome assessment in inpatient cancer care: a feasibility studyHanna Salm, Leopold Hentschel, Martin Eichler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2014
Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalanDimosthenis Andreou, Henrike Boldt, Daniel Pink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Acute hypokalemic tetraparesis induced by intravenous methotrexatePeter C Thuss-Patience, Uwe Peters, Karin Jurkat-Rott, et al.
Immunologic Research|June 8, 2004
Defining the parameters necessary for T-cell recognition of ligands that vary in potencyNeely E Kilgore, Mandy L Ford, Carrie D Margot, et al.
Anti-Cancer Drugs|September 10, 2003
Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II studyPeter C Thuss-Patience, Gunter von Minckwitz, Albrecht Kretzschmar, et al.
Investigational New Drugs|October 31, 2003
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcomaPeter Reichardt, Karin Oechsle, Daniel Pink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two casesDaniel Pink, Dagmar Schoeler, Tanja Lindner, et al.
Journal of Immunological Methods|November 27, 2012
Analysis of TCR activation kinetics in primary human T cells upon focal or soluble stimulationBoerge Arndt, Mateusz Poltorak, Bhavani S Kowtharapu, et al.
Pageof 20